Sema4 and Miami-based OPKO Health Inc., a multinational biopharmaceutical and diagnostics company, signed a definitive agreement for Sema4 to acquire OPKO’s wholly owned subsidiary, GeneDx Inc., a leader in genomic testing and analysis, for an undisclosed sum.